GLPG0187 clinical trials
Also written GLPG0187.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How each study uses GLPG0187 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- GLPG0187
- 2
Studies by the year they started
3 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses GLPG0187 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid TumorsCompletedPhase 1Galapagos NVNCT01313598Written as GLPG0187
- Bioavailability Study of Prodrug of GLPG0187 in Healthy VolunteersCompletedPhase 1Galapagos NVNCT01580644Written as GLPG0187 prodrug
- First-in-Human Single Ascending Subcutaneous (s.c.) Dose and Single Oral Dose of GLPG0187CompletedPhase 1Galapagos NVNCT00928343Written as GLPG0187
Codes
What other systems call GLPG0187 · ClinicalTrials.gg INT000564
- NCI Thesaurus C96223Integrin Receptor Antagonist GLPG0187One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| NCI Thesaurus | C96223 | Integrin Receptor Antagonist GLPG0187 | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.